Sayagcot, Normia M.
HRN: 05-85-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/23/2022
11/30/2022
IV
600 Mg
Q8H
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes